Member Article

Since 2013, the National Medical Products Administration ("NMPA")Center for Drug Evaluation("CDE")has been releasing a Drug Review Annual Report ("Report")each year, which summarizes its work on drug review of the previous year. The Reports have gradually covered key issues such as the acceptance of drug registration applications, the review and approval of drug registration applications, the expediting procedures, the communication mechanism, main issues on drug registration applications, the varieties in key therapeutic areas, and the review and approval of traditional Chinese medicines.